Niagen Bioscience, Inc. (NAGE)
4.89
+0.16
(+3.38%)
USD |
NASDAQ |
Apr 24, 11:41
Niagen Bioscience Shareholders Equity (Quarterly) : 76.53M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 198.82M |
| Nephros, Inc. | 10.20M |
| Clover Health Investments Corp. | 308.70M |
| Corcept Therapeutics, Inc. | 647.80M |
| Protalix Biotherapeutics, Inc. | 48.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.41M |
| Total Liabilities (Quarterly) | 29.87M |
| Debt to Equity Ratio | 0.0368 |
| Current Ratio | 4.86 |
| Net Debt Paydown Yield | 0.00% |